Digital Diabetes - Worldwide Industry Analysis (2019-2026) Featuring Abbott Labs, Dexcom, Roche, Insulet Corp, I-Sens, Livongo Health, Medtronic, and MoreHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Digital Diabetes - Worldwide Industry Analysis (2019-2026) Featuring Abbott Labs, Dexcom, Roche, Insulet Corp, I-Sens, Livongo Health, Medtronic, and MoreGlobeNewswireJanuary 3, 2020ReblogShareTweetShareDublin, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The "Digital Diabetes Global Market-Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.According to analysis, digital diabetes global market expected to reach $16,329.6 million by 2026 growing at a high single digit CAGR from 2019 to 2026.The digital diabetes global market is segmented based on products, end-users and geography The product market is further segmented into devices and apps and software. As estimated by the publisher, the devices global market is expected to grow at a mid single CAGR from 2019 to 2026. The apps and software global market is expected to grow at a strong double digit CAGR from 2019 to 2026 due to growing adoption of digital solutions such as cloud based software, technology advancements such as incorporating artificial intelligence to manage the diabetes are driving the market. However, privacy and data safety issues, stringent regulatory approvals, lack of reimbursement are restraining the market growth.The digital diabetes devices global market by product type is segmented into SBGM, CGM, Smart Insulin Pumps, and Smart Insulin Pens CGM accounted for the largest market revenue in 2019 and is expected to grow at a double digit CAGR from 2019 to 2026 due to increasing number of regulatory approvals for CGM systems; technological advancements in devices and other pipeline devices. SBGM products are further segmented into Smart Blood glucose meter, Blood glucose testing-strips, Lancets and control solution. Blood glucose testing-strips accounted largest revenue in 2019. CGM products are further segmented into glucose sensors and transmitter and receiver. Glucose sensor commanded the largest revenue in 2019 and is expected to grow at a double digit CAGR due to increasing adoption of CGM systems, development of advanced CGM systems, and favourable government policies in developed countries promoting the adoption of CGM systems. The smart insulin pump products are further segmented into traditional insulin pump and patch pump. Traditional insulin pump held the largest revenue in 2019 and expected to grow at a mid single digit CAGR from 2019 to 2026 and Patch pump is expected to grow at a double digit CAGR from 2019 to 2026.The Digital diabetes end-user market is segmented into home care, hospitals & private clinics and others which include ambulatory setting, academic and research institutes Homecare accounted for largest revenue in 2019. The largest revenue of this segment can be mainly attributed to technological advancements and a shift toward home care and self-management of diabetes, an increase in prevalence of diabetes disease, the improvement and acceptance of home care devices has increased. In addition, the growing focus of companies to increase awareness about diabetes and glucose management devices & apps are further driving the adoption in home care settings. Homecare is the fastest growing segment with projected high single digit CAGR from 2019 to 2026 due to the increase of self management of diabetes using apps and software at home itself.Geographical wise, the North America region commanded the largest revenue in 2019 and expected to grow at a mid single digit CAGR from 2019 to 2026 Some of the driving factors are increased awareness of the benefits of using continuous glucose monitoring systems, growing diffusion of smart devices, increasing prevalence and incidences of diabetes due to obesity and better accessibility to technologies compared to other regions and presence of well-established distribution channels of the major players in this region. However, Asia-Pacific region is expected to grow at a double digit strong CAGR from 2019 to 2026 due to a large pool of patients with diabetes, increasing patient awareness about diabetes, and increasing affordability of advanced treatment due to increasing prosperity.The digital diabetes global market is a competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares and also acquiring companies for product expansion. Some of the key players in the digital diabetes global market are Abbott Laboratories (U.S.), Dexcom, Inc. (U.S.), Insulet Corporation (U.S.), i-Sens, Inc (South Korea), Livongo Health, Inc. (U.S.), Medtronic PLC (Ireland), F.Hoffmann-LA Roche AG (Switzerland), Senseonics Holdings Inc. (U.S.), Tandem Diabetes Care (U.S.), and Ypsomed Holding AG (Switzerland).Story continuesKey Topics Covered 1 Executive Summary 2 Introduction 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers And Opportunities 3.3.1.1 The Global Rise In The Prevalence And Incidence Of Diabetes 3.3.1.2 Technological Advancements In Digital Diabetes Devices 3.3.1.3 Growing Diffusion Of Smart Devices And Digital Platforms 3.3.1.4 Increasing R&D Investments 3.3.2 Restrains And Threats 3.3.2.1 High Cost Associated With The Products 3.3.2.2 Product Recalls 3.3.2.3 Inadequate Reimbursement 3.3.2.4 Strict Regulation Of Glucose Monitoring Devices By Regulatory Organizations Like The Fda And Others 3.3.2.5 Privacy Concern And Safety Issues In Digital Diabetes 3.4 Market Share Analysis 3.4.1 Digital Diabetes Global Market Share Analysis 3.4.2 Continuous Glucose Monitor (Cgm) Market Share Analysis 3.4.3 Smart Insulin Pump Market Share Analysis 3.5 Regulatory Affairs 3.5.1 U.S. 3.5.2 Europe 3.5.3 China 3.5.4 India 3.5.5 Japan 3.6 Technological Advancements 3.6.1 Artificial Intelligence And Machine Learning 3.7 Clinical Trials 3.8 Funding Scenario 3.9 Digital Diabetes - Deals, Approvals And New Product Launch 3.10 Approval 3.11 Fda And Ce Approved Diabetes Management Apps 3.12 Product Launch 3.13 Revenue Model 3.13.1 Introduction 3.13.2 Freemium Model 3.13.3 Third Party Payment Model 3.13.4 Different Revenue Streams Model 3.13.5 Lower Pricing Model 3.13.6 New Payment Model Or New Pricing Model 3.14 Porter'S Five Force Analysis 3.14.1 Threat Of New Entrants 3.14.2 Threat Of Substitutes 3.14.3 Bargaining Power Of Suppliers 3.14.4 Bargaining Power Of Buyers 3.14.5 Rivalry Among Existing Competitors 3.15 Patent Analysis 3.16 Units Sold 3.16.1 Glucose Testing Strips Units Sold 3.16.2 Cgm Sensors Units Sold 3.16.3 Smart Insulin Pump Units Sold 3.16.4 Smart Insulin Pen Units Sold 3.17 Market Penetration 4 Digital Diabetes Global Market, By Products 4.1 Introduction 4.2 Devices 4.2.1 Smart Blood Glucose Monitoring (Sbgm) 4.2.1.1 Smart Blood Glucose Meter 4.2.1.2 Blood Glucose Testing Strips 4.2.1.3 Lancets 4.2.1.4 Others 4.2.2 Continuous Glucose Monitoring (Cgm) 4.2.2.1 Glucose Sensors 4.2.2.2 Transmitter And Receivers 4.2.3 Smart Insulin Pump 4.2.3.1 Traditional Insulin Pump 4.2.3.2 Patch Insulin Pump 4.2.4 Smart Insulin Pen 4.3 Apps And Software 5 Digital Diabetes Global Market, By End-Users 5.1 Introduction 5.2 Home Care 5.3 Hospitals And Private Clinics 5.4 Others 6 Regional Analysis 6.1 Introduction 6.2 North America 6.2.1 U.S. 6.2.2 Rest Of N.A. 6.3 Europe 6.3.1 Germany 6.3.2 France 6.3.3 Italy 6.3.4 Rest Of Europe 6.4 Asia - Pacific 6.4.1 Japan 6.4.2 China 6.4.3 India 6.4.4 Rest Of Apac 6.5 Rest Of The World 6.5.1 Brazil 6.5.2 Rest Of Latin America 6.5.3 Middle East & Others 7 Competitive Landscape 7.1 Introduction 7.2 Collaboration, Agreements And Partnerships 7.3 Approvals 7.4 New Product Launch 7.5 Acquisition 7.6 Expansion 7.7 Other Developments 8 Major Player Profiles 8.1 Abbott Laboratories8.2 Dexcom Inc.8.3 F. Hoffmann-La Roche AG8.4 Insulet Corporation8.5 I-Sens, Inc.8.6 Livongo Health, Inc.8.7 Medtronic PLC8.8 Senseonics Holdings Inc.8.9 Tandem Diabetes Care Inc.8.10 Ypsomed Holding AG List of Companies Mentioned
Abbott LaboratoriesAgamatrix Inc.AirStrip TechnologiesA. Menarini DiagnosticsAmalgam Rx, Inc.Ambrosia System IncApex Biotechnology corporationArtelusArkray Inc.Ascensia Diabetes Care Holdings AGAzumioB.Braun Melsungen AGBeatoBecton, Dickinson & CompanyBetaChekBiochemical Systems InternationalBioland TechnologyBionime CorporationBioTelemetry IncBiotest Medical CorporationBeurer GmbHBeijing Dnurse Technologies Co.,Ltd.BodyTel GmbHBrigham and Women's HospitalBrighter ABCarematrix, Inc.ChironXCompanion Medical IncDarIoHealth CorporationDebiotech S.A.Dexcom, Inc.Diabeloop S.A.DiabnextDiafyt MedTechDiamescoDigital Medics Pty LtdDottliDreaMed Diabetes LtdEli Lilly and Co.Emperra Diabetes CareEmsiG GmbH Co.Entra Health systemsEOFlowF.Hoffmann-La Roche AGFIA Biomed GmbHFitscript LLCFooducateForacare, Inc.GendiusGenesis Health TechnologyGlooko, Inc.GlucoMeGlucostratus LtdGlySens IncorporatedGlySure LimitedGlytec LLCGreiner Bio-oneH2 Inc(Health2Sync)Healthify MeHeniz Herenz Medizinalbedarf GmbHIDEAL LIFE INC.i-Health Lab Inc.IME-DC GmbHInformed Data System Inc (One Drop)InsulclockInsulet CorporationIntuity Medical, Inci-sens, Inc.IXensor Company Ltd.Jiangsu Delfu Medical Device Co.,LtdJiangsu Huida Medical Instruments Co., LtdKoninklijike Philips B.V.L-Tac MedicareLivongo Health, Inc.Lobeck Medical AGMEDISANAMedtronic PLCMedtrum Technologies, Inc.NovoNordiskNu-beca & maxcellent Co.OK Biotech Co., LtdOsang Health care co ltdOwen MumfordPepex Biomedical, Inc.Pharma Tech Solutions, Inc.Philosys incPlatinum equity (Life scan inc)POPS Diabetes Care IncProdigy Diabetes Care, LLCSaify TradersSanofi S.A.SarstedtSD BiosensorSenseonics Holdings, Inc.Sensyne HealthSirma Medical SystemsSMART Meter LLCSocial Diabetes, S.L.Sooil Development Co., LtdSpikeSweetchTaiDoc Technology CorporationTandem Diabetes careTianjin Empecs Medical Device Co.,Ltd.TidePoolTerumo CorporationTrividea Health, IncTyson bioresearch incUT Southwestern Medical CenterValeritas Inc.ViCentra B.V.VirtaHealth CorpVivaChek Laboratories, Inc.VoluntisWellDoc, Inc.Wellspan HealthYpsomed Holding AGZhejiang POCTech Co.,LtdFor more information about this report visit https://www.researchandmarkets.com/r/85aeesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextDow Jones sinks due to fears over coronavirus outbreakPA Media: World NewsFear Seen All Over Canada Market Hit By Virus, Economy ChillBloombergWhat You Must Know About Thor Explorations Ltd.'s (CVE:THX) Beta ValueSimply Wall St.This Medical Giant Was Socked In February — Is It A Safe Buy?Investor's Business DailyOne Thing To Remember About The True North Gems Inc. (CVE:TGX) Share PriceSimply Wall St.Richard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoTennessee professor charged with hiding China ties from NASAQuartzDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video